1503TiPCheckMate 592: A phase II exploratory study of biomarkers associated with the efficacy of first-line nivolumab (nivo) plus ipilimumab (ipi) in patients (pts) with stage IV or recurrent NSCLC

Saved in:

Bibliographic Details
Published in	Annals of oncology Vol. 29; no. suppl_8
Main Authors	Gettinger, S, Beck, T, Yang, X, Telivala, B, Morgensztern, D, Velcheti, V, Ramalingam, S S, Schalper, K, Dajee, M, Ranck, A, Yang, R, Spigel, D R
Format	Journal Article
Language	English
Published	Oxford University Press 01.10.2018
Online Access	Get full text

Loading…

More Information
ISSN:	0923-7534 1569-8041
DOI:	10.1093/annonc/mdy292.124